Chase Cockrell, PhD
Co-founder
Chase works on sepsis immunology, quantitative systems pharmacology and computational modeling. His research spans translational critical care, innate immune profiling and biomedical modeling.
Team
Metis Biotech brings together experience in critical care, immunology and computational modeling.
Co-founder
Chase works on sepsis immunology, quantitative systems pharmacology and computational modeling. His research spans translational critical care, innate immune profiling and biomedical modeling.
Co-founder
Gary has more than 25 years of experience in agent-based modeling of inflammation and the immune response, and was the first researcher to publish on agent-based modeling of acute inflammation and sepsis. He helped develop one of the first modular multi-organ system models of sepsis, is a member of the IMAG MSM Consortium's Subgroup on Developing Immune Digital Twins, and co-founded the Society for Complexity in Acute Illness. He has worked with Chase for the past 15 years on integrating agent-based models with AI to understand and control sepsis.